The driver of this acquisition is that Fujifilm will now have available all technologies necessary for regenerative medicine development. Wako was a 100 % subsidiary of Takeda Pharmaceutical Industry.
Fujifilm news release, December 15, 2016
The driver of this acquisition is that Fujifilm will now have available all technologies necessary for regenerative medicine development. Wako was a 100 % subsidiary of Takeda Pharmaceutical Industry.
Fujifilm news release, December 15, 2016